呋喃洛芬  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg in glass bottle
溶解性:溶于DMSO(250 mg/mL 超声)
产品描述:基本信息 产品编号:F10211 产品名称:Furaprofen CAS: 67700-30-5   储存条件 粉末 -20℃ 四年     分子式: C17H14O3 溶于液体 -80℃ 六个月 分子量 266.29 -20℃ 一个月 化学名:  7-Benzofuranacetic acid, alpha-methyl-3-phenyl-, (+-)-   Solubility (25°C)   体外 DMSO 200mg/mL (751.06mM; Need ultrasonic) Ethanol   Water   体内 现配现用   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 3.7553mL 18.7765mL 37.5530mL 5mM 0.7511mL 3.7553mL 7.5106mL 10mM 0.3755mL 1.8777mL 3.7553mL   生物活性 产品描述 一种有效的 HCV 复制抑制剂。作用于 HCV 基因型 1a 和 1b 复制子时 EC50 约为 30nM,作用于基因型 2a 复制子时 EC50 约为 1000nM。 靶点/IC50 HCV genotype 1a and 1b replicons EC50: ~30nM  HCV genotype 2a replicon ~1000nM   体外研究 Furaprofen (R803) is potent and highly specific for HCV replication. The antiviral activity of Furaprofen has been determined by a reporter replicon assay with multiple repeats to be 29.88±8.05nM, an ~3-fold improvement over the activity of the parent compound, R706. The potency of Furaprofen against the replicon is also confirmed by both Western blotting and TaqMan RT-PCR to be about 37nM and 54.67±4.11nM, respectively. To assess the general effect of Furaprofen on cell proliferation, a panel of primary cells and transformed human cell lines are treated with increasing doses of Furaprofen for 48 h, and the effect on cell proliferation is measured by an MTS-based cell viability assay. The the concentration that caused a 50% reduction in cell numbers in the absence of virus infection (CC50) of Furaprofen is found to range from 2μM to ≥10μM,depending on the cell type and proliferation status.   推荐实验方法(仅供参考) 细胞实验:   Cell Assay Replicon 9-13 cells are plated onto 6-well plates 24 h prior to the treatment. Serial dilutions of Furaprofen are made in a mixture containing 90% of the culture medium, 7.2% 1× PBS, 1.8% methanol, 1% DMSO, 20μM RBV, and varying concentrations of IFN-α for a fixed-ratio dose-response study. The cells are treated with the designated combinations of Furaprofen (0 to 80 nM concentrations) and IFN-α (0 to 4 IU/mL) plus 20μM RBV for 72 h; then they are washed with PBS,lysed in SDS loading buffer, and analyzed by Western blotting .
保存条件:-20℃